SSaSS: Salt Substitute and Stroke Study into the effect of salt substitutes on cardiovascular events and death

Professor Bruce Neal introduce the Salt Substitute and Stroke Study, which defines the overall balance of benefits and risks of salt substitutes compared with  salt in terms of cardiovascular disease, including strokes and mortality.

2021 ESC Guidelines - CVD Prevention

Prof. Frank Visseren speaks about the 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.

The current management of Angina

Prof. Marzilli speaks about the current management of Angina.

LOOP Study: screening for AF with an implantable loop recorder to prevent stroke

This study looks at whether continuous ECG monitoring using an implantable loop recorder to detect atrial fibrillation – and subsequent anticoagulation if AF is detected – will reduce the risk of stroke or systemic arterial embolism in patients at risk.

TOMAHAWK: immediate angiography after out-of-hospital cardiac arrest

This study examined whether immediate coronary angiography in survivors of out-of-hospital cardiac arrest and no ST-segment elevation is beneficial with regard to all-cause mortality at 30 days, compared with initial intensive care assessment with delayed/selective angiography.

ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation

Prof. Dangas  speaks about the outcomes of the ENVISAGE-TAVI AF trial.

2021 ESC Guidelines - Cardiac Pacing

Prof.  Glikson speaks about the 2021 ESC Guidelines on cardiac pacing and cardiac resynchronisation therapy.

The STEP Study

Prof.  Grobbee speaks about intensive vs. standard blood pressure control among older hypertensive patients.

The new advancements in angina

Prof. Gowdak speaks about the newest advnacements in the treatement of angina.

The RIPCORD 2 trial

Prof. Curzen speaks about the RIPCORD 2 trial. Does routine pressure wire assessment influence management strategy of coronary angiography for diagnosis of chest pain?

The EMPEROR-Preserved Trial

Prof. Anker speaks about the effect of empagliflozin on cardiovascular death and heart failure hospitalisations in patients with heart failure with a preserved ejection fraction, with and without diabetes.

The SMART-MI Trial

Prof. Bauer speaks about the SMART-MI-ICMs, implantable cardiac monitors in high-risk, postinfarction patients with cardiac autonomic dysfunction and moderately reduced left ventricular ejection fraction.

2021 ESC Guidelines - Heart Failure

Prof. Metra speaks about the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.

What is new about Angina?

Prof. Jankowski speaks about the current management of Angina.

2021 ESC Guidelines - Cardiac Pacing

Prof.  Nielsen speaks about the 2021 ESC Guidelines on cardiac pacing and cardiac resynchronisation therapy.

The APAF-CRT Trial

Prof. Brignole  speaks about the APAF-CRT Trial, AV junction ablation and CRT in patients with permanent atrial fibrillation and narrow QRS.